Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-22-128617)

Filing Details

Accession Number:: 0001104659-22-128617
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-12-20 16:02:02
Reporting Period:: 2022-12-13

Accepted Time:: 2022-12-20 16:02:02
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1711933	Akoya Biosciences Inc.	AKYA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1271857	P Thomas Schnettler	100 Campus Drive,6Th Floor Marlborough MA 01762		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-12-13	71,050	$13.03	2,742,721	No	4	S	Indirect	Held by Piper Sandler Merchant Banking Fund II, L.P.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	Held by Piper Sandler Merchant Banking Fund II, L.P.

Footnotes

PSC Capital Management II LLC is the general partner of Piper Sandler Merchant Banking Fund II, L.P. Piper Sandler Companies is the manager of PSC Capital Management II LLC. The reporting person is the Co-CEO of PSC Capital Management II LLC and disclaims beneficial ownership of the shares held by Piper Sandler Merchant Banking Fund II, L.P.